Letters to the Editor
Clinical Pharmacology & Therapeutics (2008); 84, 2, 204–204 doi:10.1038/clpt.2008.81
Response to "The Unanswered Question: What Is the Determinant of S-1 Pharmacokinetics?"
Y Kaida1, N Inui1,2, T Suda1, H Watanabe2 and K Chida1
- 1The Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan
- 2Department of Clinical Pharmacology and Therapeutics, Hamamatsu University School of Medicine, Hamamatsu, Japan
Correspondence: N Inui, (inui@hama-med.ac.jp)
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Response to ?The Unanswered Question: What Is the Determinant of S-1 Pharmacokinetics??Clinical Pharmacology & Therapeutics Letter
The Unanswered Question: What Is the Determinant of S-1 Pharmacokinetics?Clinical Pharmacology & Therapeutics Letter
The Unanswered Question: What Is the Determinant of S-1 Pharmacokinetics?Clinical Pharmacology & Therapeutics Letter
The CYP2A6*4 Allele Is Determinant of S-1 Pharmacokinetics in Japanese Patients With Non-small-cell Lung CancerClinical Pharmacology & Therapeutics Original Article
See all 6 matches for Research
